Takahiro Kasamatsu
Papers
2
Total Citations
22
H-Index
2
About
Dr. Takahiro Kasamatsu is a leading figure in gynecologic oncology, with a focused research agenda on the surgical de-escalation of treatment for early-stage cervical cancer. His work directly addresses the critical need to reduce the morbidity of radical surgery without compromising oncologic outcomes, particularly for younger patients. His seminal 2015 review, "Minimization of curative surgery for treatment of early cervical cancer," which has garnered 17 citations, laid the groundwork for this paradigm shift by systematically outlining the benefits of less invasive procedures. Dr. Kasamatsu’s most significant contribution is his leadership in the JCOG1101 confirmatory trial (2023), a pivotal study that prospectively evaluated modified radical hysterectomy for FIGO stage IB1 cervical cancer with tumors ≤2 cm. This high-impact trial provides the first robust evidence that a less radical, nerve-sparing approach can be safely adopted for this select patient group, potentially setting a new global standard of care. Through these efforts, Dr. Kasamatsu is at the forefront of personalizing surgical care, aiming to improve quality of life for women facing a cervical cancer diagnosis.
Research Focus
Key Achievements
Top Papers
- 1
- 2